Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency
Clinical trial NCT06237205 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06237205
- Sponsor
- Korea University Anam Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-27
- Primary completion
- 2026-06-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.